Some aspects in the quantitation of inflammation in joints of patients suffering from rheumatoid arthritis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D007596:Joints; D007719:Knee Joint; D008297:Male; D008722:Methods; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy; D010919:Placebos; D011239:Prednisolone / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use; D013667:Technetium; D013997:Time Factors; D014978:Xenon
D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D010919:Placebos; D011422:Propionates; D014978:Xenon; D013667:Technetium; D011239:Prednisolone; D001241:Aspirin